By collecting data from four different antenna orientations post-surgery, researchers are detecting significantly more detailed information on breast cancer than a traditional single-orientation scan ...

Tribe Clinical Research in Greenville has announced the launch of a new trial for a drug centered around Alzheimer's ...

Breast, bladder, and pancreatic cancers are increasingly being treated with a broad range of therapies before a patient undergoes surgery, and cancer stage at diagnosis continues to be a leading ...

Beta-blocker drugs -- commonly used to treat heart and blood pressure issues -- may slow the progression of Huntington's disease (HD), according to a new study.

At Scripps Research, a research team led by Associate Professor Anne Hanneken, in the Department of Molecular Medicine, will ...

WW International, Inc. WW stock has shown a remarkable performance in the past three months, outpacing the S&P 500 and the ...

Pathways to new treatments for heart failure take time—as long as four decades for two now accepted therapies. So, new ...

For people battling cancer, getting a chance to take part in a research trial of a new treatment can sometimes make a big difference. Starting next year, patients at the Avera Cancer Institute in ...

This innovative approach could revolutionize treatment strategies, particularly in the early phases of the illness ...

Key policies introduced over the past 45 years have brought new research organizations and investors into the pharmaceutical ...

A common heart drug may slow the progression of Huntington's disease (HD), according to a new study by University of Iowa Health Care researchers.